Economics of bladder cancer

Bishoy A. Gayed; Yair Lotan

doi:10.2217/fmeb2013.13.2

Economics of bladder cancer

Bishoy A. Gayed, Yair Lotan

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Bladder cancer carries a significant economic burden to overall healthcare costs. More cost-effective measures are needed to help alleviate the financial strain of bladder cancer. Novel approaches that reduce disease recurrence and progression, and limit severity of complications are imperative to aid with cost containment. Further research evaluating the use of urinebasedmarkers improved cystoscopy, adjuvant therapies and cost-effective surveillance protocolsmay be feasible options to lessen the costs associated with bladder cancer

Original language	English (US)
Title of host publication	Advances in Bladder Cancer Management
Publisher	Future Medicine Ltd.
Pages	90-102
Number of pages	13
ISBN (Print)	9781780844237, 9781780844251
DOIs	https://doi.org/10.2217/fmeb2013.13.2
State	Published - Oct 1 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.2217/fmeb2013.13.2

Cite this

@inbook{46c9c74ffc964432b2429cac7223e661,

title = "Economics of bladder cancer",

abstract = "Bladder cancer carries a significant economic burden to overall healthcare costs. More cost-effective measures are needed to help alleviate the financial strain of bladder cancer. Novel approaches that reduce disease recurrence and progression, and limit severity of complications are imperative to aid with cost containment. Further research evaluating the use of urinebasedmarkers improved cystoscopy, adjuvant therapies and cost-effective surveillance protocolsmay be feasible options to lessen the costs associated with bladder cancer",

author = "Gayed, {Bishoy A.} and Yair Lotan",

year = "2015",

month = oct,

day = "1",

doi = "10.2217/fmeb2013.13.2",

language = "English (US)",

isbn = "9781780844237",

pages = "90--102",

booktitle = "Advances in Bladder Cancer Management",

publisher = "Future Medicine Ltd.",

}

TY - CHAP

T1 - Economics of bladder cancer

AU - Gayed, Bishoy A.

AU - Lotan, Yair

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Bladder cancer carries a significant economic burden to overall healthcare costs. More cost-effective measures are needed to help alleviate the financial strain of bladder cancer. Novel approaches that reduce disease recurrence and progression, and limit severity of complications are imperative to aid with cost containment. Further research evaluating the use of urinebasedmarkers improved cystoscopy, adjuvant therapies and cost-effective surveillance protocolsmay be feasible options to lessen the costs associated with bladder cancer

AB - Bladder cancer carries a significant economic burden to overall healthcare costs. More cost-effective measures are needed to help alleviate the financial strain of bladder cancer. Novel approaches that reduce disease recurrence and progression, and limit severity of complications are imperative to aid with cost containment. Further research evaluating the use of urinebasedmarkers improved cystoscopy, adjuvant therapies and cost-effective surveillance protocolsmay be feasible options to lessen the costs associated with bladder cancer

UR - http://www.scopus.com/inward/record.url?scp=84956736935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956736935&partnerID=8YFLogxK

U2 - 10.2217/fmeb2013.13.2

DO - 10.2217/fmeb2013.13.2

M3 - Chapter

AN - SCOPUS:84956736935

SN - 9781780844237

SN - 9781780844251

SP - 90

EP - 102

BT - Advances in Bladder Cancer Management

PB - Future Medicine Ltd.

ER -

Economics of bladder cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this